Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21857 | 24995693 | Hepatology | The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. | 2014 | Details |
| A21858 | 24994581 | Panminerva Med | Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. | 2014 | Details |
| A21864 | 24990583 | Scand J Gastroenterol | Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD. | 2014 | Details |
| A21865 | 24990331 | Intern Med | Prognostic factors for regression from impaired glucose tolerance to normal glucose regulation in Japanese patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21876 | 24986741 | J Transl Med | Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice. | 2014 | Details |
| A21877 | 24985011 | Nutrition | Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. | 2013 | Details |
| A21885 | 24977111 | Curr Hepatol Rep | Hepatic steatosis and steatohepatitis: Are they really two distinct entities? | 2014 | Details |
| A21891 | 24976401 | Biochem Biophys Res Commun | NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease. | 2014 | Details |
| A21895 | 24975463 | Diabet Med | Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. | 2014 | Details |
| A21898 | 24974878 | Ann Gastroenterol | Insulin resistance in euglycemic cirrhosis. | 2014 | Details |
| A21899 | 24974489 | J Assoc Physicians India | Hepatocyte growth factor, adiponectin and hepatic histopathology in non-alcoholic steatohepatitis. | 2013 | Details |
| A21906 | 24968846 | Nan Fang Yi Ke Da Xue Xue Bao | [Therapeutic effect of saxagliptin in rat models of nonalcoholic fatty liver and type 2 diabetes]. | 2014 | Details |
| A21908 | 24968737 | Endocrine | Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. | 2014 | Details |
| A21909 | 24968200 | Br J Nutr | Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. | 2014 | Details |
| A21914 | 24966606 | World J Gastroenterol | Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease. | 2014 | Details |
| A21915 | 24966605 | World J Gastroenterol | Pediatric fatty liver disease: role of ethnicity and genetics. | 2014 | Details |
| A21916 | 24966604 | World J Gastroenterol | Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner? | 2014 | Details |
| A21917 | 24966603 | World J Gastroenterol | Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. | 2014 | Details |
| A21920 | 24966582 | World J Gastroenterol | Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. | 2014 | Details |
| A21924 | 24962805 | Diabetes Obes Metab | Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis. | 2014 | Details |
| A21926 | 24961681 | Pediatr Obes | Oral fructose absorption in obese children with non-alcoholic fatty liver disease. | 2014 | Details |
| A21930 | 24958099 | Mol Cell Biol | Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. | 2014 | Details |
| A21931 | 24957697 | Scand J Gastroenterol | Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21937 | 24952996 | Neurogastroenterol Motil | Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. | 2014 | Details |
| A21948 | 24944898 | Mol Metab | Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. | 2014 | Details |
| A21949 | 24944601 | Exp Ther Med | Ethanol extract of Cirsium japonicum attenuates hepatic lipid accumulation via AMPK activation in human HepG2 cells. | 2014 | Details |
| A21953 | 24939737 | Am J Physiol Endocrinol Metab | Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract. | 2014 | Details |
| A21957 | 24934631 | Eur J Pediatr | Association between nocturnal blood pressure dipping and insulin resistance in children affected by NAFLD. | 2014 | Details |
| A21964 | 24927647 | J Diabetes Complications | Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease. | 2014 | Details |
| A21969 | 24924900 | Clin Res Hepatol Gastroenterol | Burn after feeding. An old uncoupler of oxidative phosphorylation is redesigned for the treatment of nonalcoholic fatty liver disease. | 2014 | Details |
| A21979 | 24918580 | PLoS One | Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice. | 2014 | Details |
| A21980 | 24917551 | Gut | Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. | 2014 | Details |
| A21981 | 24917523 | Hepatology | Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. | 2014 | Details |
| A21985 | 24913270 | Vet Pathol | The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2014 | Details |
| A21986 | 24913135 | J Cell Mol Med | Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice. | 2014 | Details |
| A21990 | 24906975 | J Endocrinol Invest | Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women. | 2014 | Details |
| A22003 | 24899308 | Nature | The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. | 2014 | Details |
| A22016 | 24887549 | Int J Biol Macromol | Hypoglycemic and hepatoprotective effects of polysaccharides from Artemisia sphaerocephala Krasch seeds. | 2014 | Details |
| A22037 | 24858947 | PLoS One | The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats. | 2014 | Details |
| A22038 | 24858832 | PLoS One | β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice. | 2014 | Details |
| A22043 | 24854865 | FEBS J | Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress-activated protein kinases and nuclear factor-κB. | 2014 | Details |
| A22045 | 24853141 | PLoS One | HCC development is associated to peripheral insulin resistance in a mouse model of NASH. | 2014 | Details |
| A22048 | 24851523 | Trop Gastroenterol | Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India. | 2014 | Details |
| A22049 | 24850609 | Georgian Med News | [Effect of gene polymorphism of PPARgamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity]. | 2014 | Details |
| A22062 | 24845341 | Liver Int | Reduced hepatic lipid content in Pten-haplodeficient mice because of enhanced AKT2/PKBβ activation in skeletal muscle. | 2014 | Details |
| A22063 | 24845056 | Hepatology | Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. | 2014 | Details |
| A22064 | 24844310 | Eat Weight Disord | Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? | 2014 | Details |
| A22066 | 24843721 | J Diabetes Investig | Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A22067 | 24843703 | J Diabetes Investig | Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver disease. | 2013 | Details |
| A22068 | 24843689 | J Diabetes Investig | Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. | 2013 | Details |
| A22069 | 24842304 | J Hepatol | Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. | 2014 | Details |
| A22071 | 24841950 | Obes Surg | The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. | 2014 | Details |
| A22083 | 24830559 | Int J Mol Sci | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. | 2014 | Details |
| A22084 | 24829925 | J Diabetes Res | Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance. | 2014 | Details |
| A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
| A22089 | 24829591 | Hepat Mon | Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". | 2014 | Details |
| A22091 | 24828988 | Eur J Clin Invest | Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance. | 2014 | Details |
| A22096 | 24824123 | Zhonghua Gan Zang Bing Za Zhi | [Relationship of non-alcoholic steatohepatitis with arterial endothelial function and atherosclerosis]. | 2014 | Details |
| A22099 | 24823873 | Diabetes Metab Res Rev | Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. | 2014 | Details |
| A22102 | 24819989 | Steroids | Bile acids are nutrient signaling hormones. | 2014 | Details |
| A22103 | 24819229 | Metab Syndr Relat Disord | Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women. | 2014 | Details |
| A22104 | 24818764 | Gastroenterology | No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. | 2014 | Details |
| A22105 | 24816759 | Horm Metab Res | Effect of fructose and 3,5-diiodothyronine (3,5-T(2)) on lipid accumulation and insulin signalling in non-alcoholic fatty liver disease (NAFLD)-like rat primary hepatocytes. | 2014 | Details |
| A22106 | 24816727 | J Physiol Biochem | Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. | 2014 | Details |
| A22107 | 24816278 | PLoS One | Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. | 2014 | Details |
| A22111 | 24814684 | Metabolism | De novo lipogenesis in health and disease. | 2014 | Details |
| A22114 | 24811405 | Appl Microbiol Biotechnol | Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. | 2014 | Details |
| A22115 | 24806753 | Hepatology | FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. | 2014 | Details |
| A22118 | 24803810 | World J Gastroenterol | NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis. | 2014 | Details |
| A22121 | 24799990 | World J Hepatol | Pediatric non-alcoholic fatty liver disease: New insights and future directions. | 2014 | Details |
| A22122 | 24799988 | World J Hepatol | Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. | 2014 | Details |
| A22123 | 24799987 | World J Hepatol | Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. | 2014 | Details |
| A22127 | 24797980 | Adv Med Sci | Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. | 2014 | Details |
| A22128 | 24797780 | Cas Lek Cesk | [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents]. | 2014 | Details |
| A22130 | 24797416 | Sci Rep | Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. | 2014 | Details |
| A22133 | 24796105 | Nihon Rinsho | [Liver diseases]. | 2014 | Details |
| A22135 | 24795720 | Front Immunol | Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. | 2014 | Details |
| A22136 | 24795254 | Lancet Diabetes Endocrinol | Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. | 2014 | Details |
| A22139 | 24794207 | J Am Soc Hypertens | Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22142 | 24793347 | J Clin Lipidol | Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy. | 2014 | Details |
| A22146 | 24789994 | Am J Physiol Regul Integr Comp Physiol | Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity. | 2014 | Details |
| A22147 | 24788803 | Drug Saf | Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases. | 2014 | Details |
| A22151 | 24786095 | Int J Mol Sci | Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A22154 | 24784707 | Mol Cell Endocrinol | Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells. | 2014 | Details |
| A22155 | 24783906 | Med Arch | Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. | 2014 | Details |
| A22160 | 24781986 | PLoS One | Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice. | 2014 | Details |
| A22161 | 30736156 | Expert Rev Endocrinol Metab | Insulin-like growth factors (IGF-I and -II): new actors in the development of non-alcoholic fatty liver disease. | 2014 | Details |
| A22162 | 24777953 | Hepatology | Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22165 | 24775093 | J Nutr Biochem | Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome. | 2014 | Details |
| A22170 | 24769275 | Clin Biochem | Low normal thyroid function attenuates serum alanine aminotransferase elevations in the context of metabolic syndrome and insulin resistance in white people. | 2014 | Details |
| A22174 | 24768200 | Med Clin (Barc) | [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity]. | 2014 | Details |
| A22175 | 24766485 | Clin Sci (Lond) | Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice. | 2014 | Details |
| A22176 | 24766298 | Expert Opin Drug Discov | Evolving therapies for non-alcoholic steatohepatitis. | 2014 | Details |
| A22178 | 24765691 | J Indian Med Assoc | Insulin resistance and hypothyroidism: a complex relationship in non-alcoholic fatty liver disease. | 2013 | Details |
| A22179 | 24765505 | Clin Pract | Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease. | 2013 | Details |
| A22182 | 24763885 | Eur Rev Med Pharmacol Sci | Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease. | 2014 | Details |
| A22185 | 24760992 | Am J Physiol Endocrinol Metab | Mice lacking NOX2 are hyperphagic and store fat preferentially in the liver. | 2014 | Details |
| A22189 | 24758604 | BMC Gastroenterol | NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22191 | 24758097 | Invest Clin | [Hepatic steatosis, visceral fat and metabolic alterations in apparently healthy overweight/obese individuals]. | 2014 | Details |
| A22192 | 24756192 | Neurol Sci | Non-alcoholic fatty liver disease in patients with migraine. | 2014 | Details |